Cite
HARVARD Citation
Clarke, N. et al. (2019). Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial. Annals of oncology. pp. 1992-2003. [Online].